2,654
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Determination of the economically justifiable price of cenobamate in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy in Spain

ORCID Icon, , , , ORCID Icon, & show all
Pages 1127-1136 | Received 12 Apr 2022, Accepted 26 Jul 2022, Published online: 03 Aug 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.